Cargando…

Statins in the Treatment of Chronic Heart Failure: A Systematic Review

BACKGROUND: The efficacy of statin therapy in patients with established chronic heart failure (CHF) is a subject of much debate. METHODS AND FINDINGS: We conducted three systematic literature searches to assess the evidence supporting the prescription of statins in CHF. First, we investigated the pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Harst, Pim, Voors, Adriaan A, van Gilst, Wiek H, Böhm, Michael, van Veldhuisen, Dirk J
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1551909/ https://www.ncbi.nlm.nih.gov/pubmed/16933967 http://dx.doi.org/10.1371/journal.pmed.0030333

Ejemplares similares

Aging, telomeres and heart failure
por: Wong, Liza S. M., et al.
Publicado: (2010)

Renal dysfunction is associated with shorter telomere length in heart failure
por: Wong, Liza S. M., et al.
Publicado: (2009)

Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring
por: Wong, Liza S. M., et al.
Publicado: (2011)

Treating oxidative stress in heart failure: past, present and future
por: van der Pol, Atze, et al.
Publicado: (2018)

The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)
por: Haver, Vincent G, et al.
Publicado: (2014)

Treatment of heart failure with ACE inhibitors and beta-blockers: What is next? Aldosterone receptor antagonists?
por: van der Horst, Iwan C. C., et al.
Publicado: (2007)

Current and novel renal biomarkers in heart failure
por: Damman, Kevin, et al.
Publicado: (2011)

Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin
por: Ruifrok, Willem-Peter T., et al.
Publicado: (2010)

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
por: van Veldhuisen, Dirk J., et al.
Publicado: (2017)

Telomere biology in healthy aging and disease
por: Oeseburg, Hisko, et al.
Publicado: (2009)

Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial
por: Haver, Vincent G., et al.
Publicado: (2015)

Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure
por: Kobayashi, Masatake, et al.
Publicado: (2021)

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations
por: Vegter, Eline L., et al.
Publicado: (2017)

The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
por: Hoes, Martijn F., et al.
Publicado: (2019)

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011)

Emerging role of liver X receptors in cardiac pathophysiology and heart failure
por: Cannon, Megan V., et al.
Publicado: (2015)

Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population‐based cohort study
por: Meems, Laura M. G., et al.
Publicado: (2016)

Pharmacoepigenetics in Heart Failure
por: Mateo Leach, Irene, et al.
Publicado: (2010)

Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
por: Tromp, Jasper, et al.
Publicado: (2017)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

A Genome-Wide Association Study of Circulating Galectin-3
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Clinical importance of urinary sodium excretion in acute heart failure
por: Damman, Kevin, et al.
Publicado: (2020)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use
por: van der Wal, Haye H, et al.
Publicado: (2019)

Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates
por: Grote Beverborg, Niels, et al.
Publicado: (2015)

A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart Failure
por: Al-Mubarak, Ali A., et al.
Publicado: (2020)

Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial
por: ter Maaten, Jozine M., et al.
Publicado: (2023)

Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction
por: Al Ali, Lawien, et al.
Publicado: (2023)

Heart failure guidelines and prescribing in primary care across Europe
por: Sturm, Heidrun B, et al.
Publicado: (2005)

Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure
por: de Koning, Marie-Sophie L. Y., et al.
Publicado: (2023)

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
por: Boorsma, Eva M., et al.
Publicado: (2020)

The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction
por: Al Ali, Lawien, et al.
Publicado: (2016)

Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
por: Mordi, Ify R., et al.
Publicado: (2019)

Right ventricular dysfunction in patients with new‐onset heart failure: longitudinal follow‐up during guideline‐directed medical therapy
por: Ansari Ramandi, Mohammad Mostafa, et al.
Publicado: (2022)

Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis
por: Meijers, Wouter C., et al.
Publicado: (2014)

Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction
por: Schroten, Nicolas F., et al.
Publicado: (2015)

Age dependent associations of risk factors with heart failure: pooled population based cohort study
por: Tromp, Jasper, et al.
Publicado: (2021)

Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
por: Yin, Meimei, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e4h11tejss8ksgk6t79u0ahc8n